FEATURED FUNDS
ICICI Prudential Large & Mid Cap Fund Direct Pla..
5Y Return
14.65 %
Invest Now
FEATURED FUNDS
ICICI Prudential Multicap Fund Direct Plan-Growt..
5Y Return
14.16 %
Invest Now
FEATURED FUNDS
ICICI Prudential Long Term Equity Fund (Tax Savi..
5Y Return
14.22 %
Invest Now
FEATURED FUNDS
ICICI Prudential Bluechip Fund Direct-Growth
5Y Return
15.16 %
Invest Now
FEATURED FUNDS
ICICI Prudential Smallcap Fund Direct Plan-Growt..
5Y Return
15.94 %
Invest Now
Business News›News›Morning Brief Podcast›Morning Brief: Pat(i)ent rights: Will waiver of IP rights on Covid vaccines, drugs help developing nations like India?
TUNE IN NOW FOR NEWS & VIEWS
Morning Brief (ET Bureau)
Pat(i)ent rights: Will waiver of IP rights on Covid vaccines, drugs help developing nations like India?
Devina Sengupta | 21:31 Min | May 11, 2021, 8:00 AM IST
A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, former global general counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, ET Prime, explain what’s at stake for the patent holders and developing nations. The clip featuring Bill Gates used in the podcast belongs to Sky News.
Transcript
Host: Devina Sengupta
